NCT07107737 Physician Engagement in EMS Transport Refusal Rates
| NCT ID | NCT07107737 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Wake Forest University Health Sciences |
| Condition | Refusal of Transport |
| Study Type | INTERVENTIONAL |
| Enrollment | 250 participants |
| Start Date | 2026-04-12 |
| Primary Completion | 2026-10 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 250 participants in total. It began in 2026-04-12 with a primary completion date of 2026-10.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The primary goal of this study is to find out if patients who speak with an EMS physician over the phone are less likely to refuse care compare to patients who do not speak with an EMS physician.
Eligibility Criteria
Inclusion Criteria: • Adult patients ≥18 years old in care of Mecklenburg EMS (MEDIC) on an emergency basis (911 call) who wish to refuse transportation to the hospital in whom MEDIC has, via existing processes and decision-making, engaged online medical control EMS Physicians for further guidance Exclusion Criteria: * Patients \<18 years old. * Patient refuses to speak with online medical control EMS Physicians. MEDIC or patient requests to have primary care physician. * Lack of clinical capacity. * Incarcerated population.
Contact & Investigator
Stephen Tyler Constantine, MD
PRINCIPAL INVESTIGATOR
Atrium Health Carolinas Medical Center
Frequently Asked Questions
Who can join the NCT07107737 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Refusal of Transport. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07107737 currently recruiting?
Yes, NCT07107737 is actively recruiting participants. Contact the research team at stephen.constantine@advocatehealth.org for enrollment information.
Where is the NCT07107737 trial being conducted?
This trial is being conducted at Charlotte, United States.
Who is sponsoring the NCT07107737 clinical trial?
NCT07107737 is sponsored by Wake Forest University Health Sciences. The principal investigator is Stephen Tyler Constantine, MD at Atrium Health Carolinas Medical Center. The trial plans to enroll 250 participants.